Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
18.48
-0.09 (-0.48%)
At close: Oct 30, 2026, 4:00 PM EDT
19.89
+1.41 (7.63%)
After-hours: Oct 30, 2026, 7:56 PM EDT
Nuvectis Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 22.16 | 25.13 | 31.63 | 35.44 | 26.79 | 29.86 | 18.53 | 17.17 | 18.12 | 19.46 | 19.13 | 22.06 | 24.6 | 15.47 | 19.99 | 23.64 | 13.57 | 16.69 | 5.74 | - |
Cash & Short-Term Investments | 22.16 | 25.13 | 31.63 | 35.44 | 26.79 | 29.86 | 18.53 | 17.17 | 18.12 | 19.46 | 19.13 | 22.06 | 24.6 | 15.47 | 19.99 | 23.64 | 13.57 | 16.69 | 5.74 | - |
Cash Growth (YoY) | -17.29% | -15.85% | 70.69% | 106.43% | 47.90% | 53.43% | -3.10% | -22.17% | -26.36% | 25.83% | -4.34% | -6.69% | 81.26% | -7.34% | 248.19% | - | - | - | - | - |
Other Current Assets | 0.22 | 0.27 | 0.08 | 0.15 | 0.21 | 0.28 | 0.07 | 0.14 | 0.18 | 0.25 | 0.06 | 0.2 | 0.34 | 0.74 | 0.41 | 1.23 | 0.67 | 0.93 | 0.09 | - |
Total Current Assets | 22.38 | 25.4 | 31.71 | 35.59 | 27.01 | 30.15 | 18.61 | 17.31 | 18.3 | 19.71 | 19.19 | 22.26 | 24.94 | 16.21 | 20.41 | 24.87 | 14.24 | 17.62 | 5.83 | - |
Long-Term Deferred Charges | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.82 | - |
Total Assets | 22.38 | 25.4 | 31.71 | 35.59 | 27.01 | 30.15 | 18.61 | 17.31 | 18.3 | 19.71 | 19.19 | 22.26 | 24.94 | 16.21 | 20.41 | 24.87 | 14.24 | 17.62 | 6.66 | - |
Liabilities
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Accounts Payable | 5.18 | 4.7 | 6.27 | 6.44 | 4.98 | 2.99 | 2.5 | 2.26 | 1.85 | 1.76 | 2.77 | 3.49 | 1.8 | 2.1 | 2.91 | 2.25 | 1.43 | 1.35 | 1.06 | 0.01 |
Accrued Expenses | 6.72 | 6.48 | 7.02 | 5.06 | 5.08 | 5.9 | 6.4 | 4.05 | 3.92 | 3.93 | 4.21 | 2.08 | 2.41 | 1.84 | 2.83 | 1.6 | 0.96 | 0.79 | 0.54 | - |
Other Current Liabilities | 1.39 | - | - | 0.08 | 0.08 | 0.3 | - | - | - | - | - | - | 0.4 | - | 0.45 | 0.64 | 0.34 | 0.92 | 0.82 | - |
Total Current Liabilities | 13.29 | 11.18 | 13.3 | 11.58 | 10.14 | 9.19 | 8.89 | 6.32 | 5.77 | 5.69 | 6.98 | 5.58 | 4.61 | 3.93 | 6.19 | 4.49 | 2.74 | 3.06 | 2.42 | 0.01 |
Total Liabilities | 13.29 | 11.18 | 13.3 | 11.58 | 10.14 | 9.19 | 8.89 | 6.32 | 5.77 | 5.69 | 6.98 | 5.58 | 4.61 | 3.93 | 6.19 | 4.49 | 2.74 | 3.06 | 2.42 | 0.01 |
Shareholders' Equity
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Additional Paid-In Capital | 121.84 | 119.96 | 118.1 | 116.38 | 101.78 | 99.53 | 82.96 | 77.99 | 75.37 | 72.44 | 66.45 | 64.31 | 62.07 | 48.31 | 46.2 | 45.66 | 30.91 | 30.4 | 1.89 | - |
Retained Earnings | -112.76 | -105.74 | -99.69 | -92.37 | -84.91 | -78.58 | -73.25 | -67 | -62.84 | -58.42 | -54.25 | -47.62 | -41.74 | -36.03 | -31.99 | -25.29 | -19.41 | -15.84 | -12.9 | -0.01 |
Total Common Equity | 9.08 | 14.22 | 18.41 | 24.01 | 16.87 | 20.95 | 9.71 | 10.99 | 12.53 | 14.02 | 12.2 | 16.69 | 20.33 | 12.27 | 14.22 | 20.37 | 11.5 | 14.56 | -11.01 | -0.01 |
Shareholders' Equity | 9.08 | 14.22 | 18.41 | 24.01 | 16.87 | 20.95 | 9.71 | 10.99 | 12.53 | 14.02 | 12.2 | 16.69 | 20.33 | 12.27 | 14.22 | 20.37 | 11.5 | 14.56 | 4.24 | -0.01 |
Total Liabilities & Equity | 22.38 | 25.4 | 31.71 | 35.59 | 27.01 | 30.15 | 18.61 | 17.31 | 18.3 | 19.71 | 19.19 | 22.26 | 24.94 | 16.21 | 20.41 | 24.87 | 14.24 | 17.62 | 6.66 | - |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Cash (Debt) | 22.16 | 25.13 | 31.63 | 35.44 | 26.79 | 29.86 | 18.53 | 17.17 | 18.12 | 19.46 | 19.13 | 22.06 | 24.6 | 15.47 | 19.99 | 23.64 | 13.57 | 16.69 | 5.74 | - |
Net Cash Growth (YoY) | -17.29% | -15.85% | 70.69% | 106.43% | 47.90% | 53.43% | -3.10% | -22.17% | -26.36% | 25.83% | -4.34% | -6.69% | 81.26% | -7.34% | 248.19% | - | - | - | - | - |
Net Cash Per Share | 0.95 | 1.11 | 1.45 | 1.73 | 1.40 | 1.66 | 1.08 | 1.03 | 1.10 | 1.22 | 1.23 | 1.45 | 1.68 | 1.10 | 1.58 | 2.34 | 1.75 | 2.99 | 1.35 | - |
Filing Date Shares Outstanding | 32.58 | 26.53 | 26.49 | 25.61 | 25.46 | 23.63 | 23.39 | 19.32 | 18.65 | 18.36 | 17.77 | 17.33 | 17.22 | 16.01 | 14.75 | 14.64 | 14.64 | 12.72 | 12.72 | 3.9 |
Total Common Shares Outstanding | 26.69 | 26.53 | 25.68 | 25.64 | 23.88 | 23.63 | 19.5 | 18.99 | 18.75 | 18.36 | 17.42 | 17.31 | 17.22 | 15.89 | 14.64 | 14.64 | 12.72 | 12.72 | 4.51 | 3.9 |
Working Capital | 9.08 | 14.22 | 18.41 | 24.01 | 16.87 | 20.95 | 9.71 | 10.99 | 12.53 | 14.02 | 12.2 | 16.69 | 20.33 | 12.27 | 14.22 | 20.37 | 11.5 | 14.56 | 3.41 | -0.01 |
Book Value Per Share | 0.34 | 0.54 | 0.72 | 0.94 | 0.71 | 0.89 | 0.50 | 0.58 | 0.67 | 0.76 | 0.70 | 0.96 | 1.18 | 0.77 | 0.97 | 1.39 | 0.90 | 1.14 | -2.44 | -0.00 |
Tangible Book Value | 9.08 | 14.22 | 18.41 | 24.01 | 16.87 | 20.95 | 9.71 | 10.99 | 12.53 | 14.02 | 12.2 | 16.69 | 20.33 | 12.27 | 14.22 | 20.37 | 11.5 | 14.56 | -11.01 | -0.01 |
Tangible Book Value Per Share | 0.34 | 0.54 | 0.72 | 0.94 | 0.71 | 0.89 | 0.50 | 0.58 | 0.67 | 0.76 | 0.70 | 0.96 | 1.18 | 0.77 | 0.97 | 1.39 | 0.90 | 1.14 | -2.44 | -0.00 |